Grant Maclaine - Concepedia

Author

Grant Maclaine

Also Known As

E. Cerasi, G MacLaine, G Maclaine, G. D. H. Maclaine, G. Maclaine, G.D.H. Maclaine, Grant D. H. Maclaine, Grant D.H. Maclaine, Grant Maclaine

Publications

826

Citations

H-Index

Concepts

All Affiliations

Eisai (United Kingdom)United BioSource Corporation (United Kingdom)Health Economics and Outcomes Research (United Kingdom)Becton Dickinson (United States)Becton Dickinson (United Kingdom)

About

Grant Maclaine is an author at Eisai (United Kingdom) specializing in medicine, outcomes research, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	166
2	Public Health	1	1	16
3	Diabetes	1	1	16
4	Gastroenterology	1	1	24
5	Geriatrics	1	1	76

Grant Maclaine

Publications

670

Citations

H-Index

Page 1

	Year	Citations
An economic evaluation of early assessment for Alzheimer's disease in the United Kingdom D Getsios, Steve Blume, K. Jack Ishak, Alzheimer s & Dementia	2011	142
Patient-reported Symptoms of Tenosynovial Giant Cell Tumors Heather L. Gelhorn, Sandra Tong, Kelly McQuarrie, Clinical Therapeutics	2016	105
Assessing patient outcomes in acute exacerbations of chronic bronchitis: The measure your medical outcome profile (MYMOP), medical outcomes study 6-item general health survey (MOS-6A) and EuroQol (EQ-5D) Charlotte Paterson, C. E. Langan, G.A. McKaig, Quality of Life Research	2000	83
Cost Effectiveness of Donepezil in the Treatment of Mild to Moderate Alzheimerʼs Disease Denis Getsios, Steve Blume, K. Jack Ishak, PharmacoEconomics Alzheimer's DiseaseGeriatricsMedicineTreatment EvaluationPharmacoeconomics	2010	76
VALACICLOVIR PROPHYLAXIS OF CYTOMEGALOVIRUS INFECTION AND DISEASE IN RENAL TRANSPLANTATION: AN ECONOMIC EVALUATION Christophe M. Legendre, Douglas J. Norman, Michael R. Keating, Transplantation	2000	50
Evaluating the cost effectiveness of donepezil in the treatment of Alzheimer's disease in Germany using discrete event simulation Susanne Hartz, Denis Getsios, Sunning Tao, BMC Neurology	2012	39
Economic benefits of safety-engineered sharp devices in Belgium - a budget impact model Emma Hanmore, Grant Maclaine, Fiona Garin, BMC Health Services Research	2013	36
The measurement of physical functioning among patients with Tenosynovial Giant Cell Tumor (TGCT) using the Patient-Reported Outcomes Measurement Information System (PROMIS) Heather L. Gelhorn, Xin Ye, Rebecca M. Speck, Journal of Patient-Reported Outcomes	2019	28
Cost-Effectiveness Model of Cytomegalovirus Management Strategies in Renal Transplantation Josephine Mauskopf, Anke Richter, Lieven Annemans, PharmacoEconomics Translational MedicineTransplantationKidney TransplantCost-effectiveness ModelKidney Transplantation	2000	27
The Cost Effectiveness of Rufinamide in the Treatment of Lennox-Gastaut Syndrome in the UK Ágnes Benedict, L Verdian, Grant Maclaine PharmacoEconomics GastroenterologyOutcomes ResearchPharmacotherapySurgeryCost Effectiveness	2010	24

Page 1